-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, KdS7PedsJ1ZoXUijUR2FIn+u4xWX+QNBIsnYR7KxENBNcfyc88wEgWg9xbJ0oRrF aKvtG9BsSrHdX6dH76XMmA== 0000950148-97-000390.txt : 19970222 0000950148-97-000390.hdr.sgml : 19970222 ACCESSION NUMBER: 0000950148-97-000390 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19970214 SROS: NONE SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ACCUMED INTERNATIONAL INC CENTRAL INDEX KEY: 0000888335 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 364054899 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-47187 FILM NUMBER: 97534491 BUSINESS ADDRESS: STREET 1: 920 N FRANKLIN ST STREET 2: STE 402 CITY: CHICAGO STATE: IL ZIP: 60610 BUSINESS PHONE: 3126429200 MAIL ADDRESS: STREET 1: 920 N FRANKLIN STREET STREET 2: SUITE 402 CITY: CHICAGO STATE: IL ZIP: 60610 FORMER COMPANY: FORMER CONFORMED NAME: ALAMAR BIOSCIENCES INC DATE OF NAME CHANGE: 19950504 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: GOMBRICH PETER P CENTRAL INDEX KEY: 0001006222 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 920 N FRANKLIN ST STREET 2: SUITE 402 CITY: CHICAGO STATE: IL ZIP: 60610 MAIL ADDRESS: STREET 2: 920 NORTH FRANKLIN STREET SUITE401 CITY: CHICAGO STATE: IL ZIP: 60610 SC 13G/A 1 AMENDMENT NO. 1 TO SCHEDULE 13G 1 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities and Exchange Act of 1934 Amendment No. 1 AccuMed International, Inc. - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock, $.01 par value - -------------------------------------------------------------------------------- (Title of Class of Securities) 004383105 - -------------------------------------------------------------------------------- (CUSIP Number) 2 CUSIP NO. 004383105 --------------------- 1. NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON PETER P. GOMBRICH --------------------------------------------------------------------- 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [ X ] --------------------------------------------------------------------- 3. SEC USE ONLY --------------------------------------------------------------------- 4. CITIZENSHIP OR PLACE OF ORGANIZATION U.S.A. --------------------------------------------------------------------- 5. SOLE VOTING POWER NUMBER OF 3,099,800 SHARES -------------------------------------------------------- BENEFICIALLY 6. SHARED VOTING POWER OWNED BY 0 EACH -------------------------------------------------------- REPORTING 7. SOLE DISPOSITIVE POWER PERSON WITH 3,099,800 -------------------------------------------------------- 8. SHARED DISPOSITIVE POWER 0 -------------------------------------------------------- 3 CUSIP NO. 004383105 ----------------- 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 3,099,800 --------------------------------------------------------------------- 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ X ] --------------------------------------------------------------------- 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 14% --------------------------------------------------------------------- 12. TYPE OF REPORTING PERSON IN --------------------------------------------------------------------- Item 1(a). Name of Issuer: AccuMed International, Inc. Item 1(b). Address of Issuer's Principal Executive Offices: 900 North Franklin Street, Suite 401 Chicago, Illinois 60610 Item 2(a). Name of Person Filing: Peter P. Gombrich Item 2(b). Address of Principal Business Office, or, if None, Residence: 900 North Franklin Street, Suite 401 Chicago, Illinois 60610 Item 2(c). Citizenship: U.S.A. Item 2(d). Title and Class of Securities: Common Stock, $.01 par value 4 CUSIP NO. 004383105 ----------------- Item 2(e). CUSIP Number: 004383105 Item 3. If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b), check whether the person filing is a: (a). [ ] Broker or dealer registered under Section 15 of the Act (b). [ ] Bank as defined in Section 3(a)(6) of the Act (c). [ ] Insurance Company as defined in Section 3(a)(19) of the Act (d). [ ] Investment Company registered under Section 8 of the Investment Company Act (e). [ ] Investment Adviser registered under Section 203 of the Investment Advisers Act of 1940 (f). [ ] Employee Benefit Plan, Pension Fund which is subject to the provisions of the Employee Retirement Income Security Act of 1974 or Endowment Fund; see 13d-1(b)(1)(ii)(F) (g). [ ] Parent Holding Company, in accordance with Rule 13d-1(b)(ii)(G) (Note: See Item 7) (h). [ ] Group, in accordance with Rule 13d-1(b)(ii)(H) Item 4. Ownership. (a). Amount beneficially owned: As of December 31, 1996, Mr. Gombrich beneficially owned 3,099,800 shares of Common Stock, which include the right to acquire 133,334 shares of Common Stock within 60 days of December 31, 1996. Includes 537,381 shares of Common Stock subject to forfeiture if AccuMed International, Inc., fails to meet certain earnings per share or stock price performance thresholds during 1997. The amount beneficially owned by Mr. Gombrich does not include 180,646 shares of Common Stock owned directly and beneficially by Gwenda Gombrich (who is Mr. Gombrich's wife) and 333,152 shares of 5 CUSIP NO. 004383105 ----------------- Common Stock owned directly and beneficially by Ms. Gombrich as custodian for her children, as to which Mr. Gombrich disclaims beneficial ownership. (b). Percent of class: See the response(s) to Item 11 on the cover page(s). (c). Number of shares as to which such person has: (i) Sole power to vote or to direct the vote: See the response(s) to Item 5 on the attached cover page(s). (ii) Shared power to vote or direct the vote: See the response(s) to Item 6 on the attached cover page(s). (iii) Sole power to dispose or to direct the disposition of: See the response(s) to Item 7 on the attached cover page(s). (iv) Shared power to dispose or to direct the disposition of: See the response(s) to Item 8 on the attached cover page(s). Item 5. Ownership of Five Percent or Less of a Class. Not Applicable Item 6. Ownership of More than Five Percent on Behalf of Another Person. Not Applicable Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company. Not Applicable 6 CUSIP NO. 004383105 ----------------- Item 8. Identification and Classification of Members of the Group. Not Applicable Item 9. Notice of Dissolution of Group. Not Applicable Item 10. Certification. Not Applicable SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: February 12, 1997 /s/ Peter P. Gombrich -------------------------------------- Name: Peter P. Gombrich -----END PRIVACY-ENHANCED MESSAGE-----